⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5649622 | 0.69 | — | — | |
| SCHEMBL27954493 | 0.69 | — | — | |
| SCHEMBL27954494 | 0.69 | — | — | |
| SCHEMBL1701532 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL27737616 | 0.67 | — | — | |
| SCHEMBL6833007 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL27564798 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL27976857 | 0.67 | LPO (0.48) | — | |
| SCHEMBL25219157 | 0.64 | — | — | |
| SCHEMBL31252019 | 0.64 | TLR8 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118772869-A | Composite thermochromic fluorescent material and preparation method and application thereof | 苏州科技大学 | 2024-10-15 | — | — | CN | claimed |
| CN-118581738-A | Preparation method of patterned local super-hydrophobic breathable cotton fabric based on ink-jet printing technology | 青岛大学 | 2024-09-03 | — | — | CN | claimed |
| WO-2023122498-A1 | ONE-STEP OXIDE BATH FOR IMPROVING ADHESION OF POLYMERIC MATERIALS TO METAL SUBSTRATES | MACDERMID, INCORPORATED (US) | 2023-06-29 | — | — | WO | claimed |
| US-20230199972-A1 | One-Step Oxide Bath for Improving Adhesion of Polymeric Materials to Metal Substrates | MACDERMID, INCORPORATED | 2023-06-22 | — | — | US | claimed |
| CN-114479479-B | Preparation method of black phosphorus-metal organic framework composite material synthesized in limited area | 上海忒尔苏斯环境科技合伙企业(有限合伙) | 2023-05-12 | — | — | CN | claimed |
| US-20230123029-A1 | ZIF NANOPARTICLE CONTAINING TRI-LIGANDS, THE METHOD OF MANUFACTURING THE SAME, MIXED MATRIX MEMBRANE COMPRISING THE SAME AND METHOD OF SEPARATING GAS USING THE MEMBRANE | SOGANG UNIVERSITY RESEARCH ＆ BUSINESS DEVELOPMENT FOUNDATION (KR) | 2023-04-20 | — | — | US | claimed |
| CN-114015063-B | Nitro-ligand-doped zeolitic imidazolate framework material ZIF-71-clnIm x Preparation and use of | 太原理工大学 | 2023-01-10 | — | — | CN | claimed |
| US-20220235090-A1 | OLIGONUCLEOTIDE MANUFACTURING METHOD | AJINOMOTO CO., INC. (JP) | 2022-07-28 | — | — | US | claimed |
| US-11344850-B2 | Nanocomposite membranes and methods of forming the same | Tsapatsis, Michael (US) | 2022-05-31 | — | — | US | claimed |
| CN-114479479-A | Preparation method for synthesizing black phosphorus-metal organic framework composite material in limited domain | 上海忒尔苏斯环境科技合伙企业(有限合伙) | 2022-05-13 | — | — | CN | claimed |
| CN-110842192-A | Nitrogen-doped porous carbon-coated hydrogen storage alloy powder and preparation method thereof | 四川大学 | 2020-02-28 | — | — | CN | claimed |
| US-20190168173-A1 | NANOCOMPOSITE MEMBRANES AND METHODS OF FORMING THE SAME | MICHAEL TSAPATSIS | 2019-06-06 | — | — | US | claimed |
| US-20180291056-A1 | OLIGONUCLEOTIDE MANUFACTURING METHOD | AJINOMOTO CO., INC. (JP) | 2018-10-11 | — | — | US | claimed |
| US-20090170847-A1 | Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same | YUYU PHARMA, INC. (KR) | 2009-07-02 | — | — | US | claimed |
| EP-1984370-A1 | IMIDAZOPYRIDINE DERIVATIVES INHIBITING PROTEIN KINASE ACTIVITY, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Crystalgenomics, Inc. (KR) | 2008-10-29 | — | — | EP | claimed |
| WO-2007083978-A1 | IMIDAZOPYRIDINE DERIVATIVES INHIBITING PROTEIN KINASE ACTIVITY, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | CRYSTALGENOMICS, INC. (KR) | 2007-07-26 | — | — | WO | claimed |
| EP-0933681-A1 | Positive-tone photoimageable crosslinkable coating | MORTON INTERNATIONAL, INC. (US) | 1999-08-04 | — | — | EP | claimed |
| EP-0859282-A1 | Positive-tone photoimageable crosslinkable coating | MORTON INTERNATIONAL, INC. (US) | 1998-08-19 | — | — | EP | claimed |
| EP-4741411-A2 | OLIGONUCLEOTIDE PRODUCTION METHOD, AND NUCLEOSIDE, NUCLEOTIDE, OR OLIGONUCLEOTIDE | AJINOMOTO CO., INC. (JP) | 2026-05-13 | — | — | EP | disclosed |
| EP-0284405-A2 | Anti-viral compounds, dosage forms and methods | BAKER NORTON PHARMACEUTICALS, INC. (US) | 1988-09-28 | — | — | EP | disclosed |